Identifying the Hub Genes for Duchenne Muscular Dystrophy and Becker Muscular Dystrophy by Weighted Correlation Network Analysis

Overview

Journal BMC Genom Data

Publisher Biomed Central

Specialty Genetics

Date 2021 Dec 19

PMID 34922439

Citations 5

Authors

Junjie Wang

Qin Fan

Tengbo Yu

Yingze Zhang

Affiliations

Soon will be listed here.

Abstract

Background: The goal of this study is to identify the hub genes for Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) via weighted correlation network analysis (WGCNA).

Methods: The gene expression profile of vastus lateralis biopsy samples obtained in 17 patients with DMD, 11 patients with BMD and 6 healthy individuals was downloaded from the Gene Expression Omnibus (GEO) database (GSE109178). After obtaining different expressed genes (DEGs) via GEO2R, WGCNA was conducted using R package, modules and genes that highly associated with DMD, BMD, and their age or pathology were screened. Gene Ontology (GO) and Kyoto Encyclopaedia of Genes and Genomes (KEGG) enrichment analysis and protein-protein interaction (PPI) network analysis were also conducted. Hub genes and highly correlated clustered genes were identified using Search Tool for the Retrieval of Interacting Genes (STRING) and Cystoscape software.

Results: One thousand four hundred seventy DEGs were identified between DMD and control, with 1281 upregulated and 189 downregulated DEGs. Four hundred and twenty DEGs were found between BMD and control, with 157 upregulated and 263 upregulated DEGs. Fourteen modules with different colors were identified for DMD vs control, and 7 modules with different colors were identified for BMD vs control. Ten hub genes were summarized for DMD and BMD respectively, 5 hub genes were summarized for BMD age, 5 and 3 highly correlated clustered genes were summarized for DMD age and BMD pathology, respectively. In addition, 20 GO enrichments were found to be involved in DMD, 3 GO enrichments were found to be involved in BMD, 3 GO enrichments were found to be involved in BMD age.

Conclusion: In DMD, several hub genes were identified: C3AR1, TLR7, IRF8, FYB and CD33(immune and inflammation associated genes), TYROBP, PLEK, AIF1(actin reorganization associated genes), LAPTM5 and NT5E(cell death and arterial calcification associated genes, respectively). In BMD, a number of hub genes were identified: LOX, ELN, PLEK, IKZF1, CTSK, THBS2, ADAMTS2, COL5A1(extracellular matrix associated genes), BCL2L1 and CDK2(cell cycle associated genes).

Citing Articles

Exploring novel natural compound-based therapies for Duchenne muscular dystrophy management: insights from network pharmacology, QSAR modeling, molecular dynamics, and free energy calculations.

Saeed M, Haque A, Shoaib A, Danish Rizvi S Front Pharmacol. 2024; 15:1395014.

PMID: 39415830 PMC: 11481126. DOI: 10.3389/fphar.2024.1395014.

Brothers with Becker muscular dystrophy show discordance in skeletal muscle computed tomography findings: A case report.

Nambu Y, Shirakawa T, Osawa K, Nishio H, Nozu K, Matsuo M SAGE Open Med Case Rep. 2024; 12:2050313X231221436.

PMID: 38187815 PMC: 10768573. DOI: 10.1177/2050313X231221436.

Identification of Auxiliary Biomarkers and Description of the Immune Microenvironmental Characteristics in Duchenne Muscular Dystrophy by Bioinformatical Analysis and Experiment.

Han X, Han J, Wang N, Ji G, Guo R, Li J Front Neurosci. 2022; 16:891670.

PMID: 35720684 PMC: 9204148. DOI: 10.3389/fnins.2022.891670.

Application of Droplet Digital PCR Technology in Muscular Dystrophies Research.

Lambrescu I, Popa A, Manole E, Ceafalan L, Gaina G Int J Mol Sci. 2022; 23(9).

PMID: 35563191 PMC: 9099497. DOI: 10.3390/ijms23094802.

Molecular Fingerprint of BMD Patients Lacking a Portion in the Rod Domain of Dystrophin.

Capitanio D, Moriggi M, Barbacini P, Torretta E, Moroni I, Blasevich F Int J Mol Sci. 2022; 23(5).

PMID: 35269765 PMC: 8910510. DOI: 10.3390/ijms23052624.

References

Blake D, Weir A, Newey S, Davies K . Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol Rev. 2002; 82(2):291-329. DOI: 10.1152/physrev.00028.2001. View

Gruber H, Ingram J, Hoelscher G, Zinchenko N, Norton H, Hanley Jr E . Constitutive expression of cathepsin K in the human intervertebral disc: new insight into disc extracellular matrix remodeling via cathepsin K and receptor activator of nuclear factor-κB ligand. Arthritis Res Ther. 2011; 13(4):R140. PMC: 3239383. DOI: 10.1186/ar3454. View

Inoue J, Misawa A, Tanaka Y, Ichinose S, Sugino Y, Hosoi H . Lysosomal-associated protein multispanning transmembrane 5 gene (LAPTM5) is associated with spontaneous regression of neuroblastomas. PLoS One. 2009; 4(9):e7099. PMC: 2746316. DOI: 10.1371/journal.pone.0007099. View

Cui D, Zhao Y, Xu J . Activation of CXCL5-CXCR2 axis promotes proliferation and accelerates G1 to S phase transition of papillary thyroid carcinoma cells and activates JNK and p38 pathways. Cancer Biol Ther. 2018; 20(5):608-616. PMC: 6606038. DOI: 10.1080/15384047.2018.1539289. View

Mendell J, Shilling C, Leslie N, Flanigan K, Al-Dahhak R, Gastier-Foster J . Evidence-based path to newborn screening for Duchenne muscular dystrophy. Ann Neurol. 2012; 71(3):304-13. DOI: 10.1002/ana.23528. View

Regensburger A, Fonteyne L, Jungert J, Wagner A, Gerhalter T, Nagel A . Detection of collagens by multispectral optoacoustic tomography as an imaging biomarker for Duchenne muscular dystrophy. Nat Med. 2019; 25(12):1905-1915. DOI: 10.1038/s41591-019-0669-y. View

Colussi C, Banfi C, Brioschi M, Tremoli E, Straino S, Spallotta F . Proteomic profile of differentially expressed plasma proteins from dystrophic mice and following suberoylanilide hydroxamic acid treatment. Proteomics Clin Appl. 2010; 4(1):71-83. DOI: 10.1002/prca.200900116. View

Puri T, Quigg R . The many effects of complement C3- and C5-binding proteins in renal injury. Semin Nephrol. 2007; 27(3):321-37. DOI: 10.1016/j.semnephrol.2007.02.005. View

Jeong H, Shin J, Lee K, Lee S, Chong H, Jeong H . Caffeoyl-Prolyl-Histidine Amide Inhibits Fyn and Alleviates Atopic Dermatitis-Like Phenotypes via Suppression of NF-κB Activation. Int J Mol Sci. 2020; 21(19). PMC: 7582254. DOI: 10.3390/ijms21197160. View

10.

Waldrop M, Flanigan K . Update in Duchenne and Becker muscular dystrophy. Curr Opin Neurol. 2019; 32(5):722-727. DOI: 10.1097/WCO.0000000000000739. View

11.

Hamaguchi N, Ihara S, Ohdaira T, Nagano H, Iwamatsu A, Tachikawa H . Pleckstrin-2 selectively interacts with phosphatidylinositol 3-kinase lipid products and regulates actin organization and cell spreading. Biochem Biophys Res Commun. 2007; 361(2):270-5. DOI: 10.1016/j.bbrc.2007.06.132. View

12.

Birnkrant D, Bushby K, Bann C, Apkon S, Blackwell A, Brumbaugh D . Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol. 2018; 17(3):251-267. PMC: 5869704. DOI: 10.1016/S1474-4422(18)30024-3. View

13.

Colige A, Nuytinck L, Hausser I, van Essen A, Thiry M, Herens C . Novel types of mutation responsible for the dermatosparactic type of Ehlers-Danlos syndrome (Type VIIC) and common polymorphisms in the ADAMTS2 gene. J Invest Dermatol. 2004; 123(4):656-63. DOI: 10.1111/j.0022-202X.2004.23406.x. View

14.

Emery A . The muscular dystrophies. Lancet. 2002; 359(9307):687-95. DOI: 10.1016/S0140-6736(02)07815-7. View

15.

Kohler C . Allograft inflammatory factor-1/Ionized calcium-binding adapter molecule 1 is specifically expressed by most subpopulations of macrophages and spermatids in testis. Cell Tissue Res. 2007; 330(2):291-302. DOI: 10.1007/s00441-007-0474-7. View

16.

Kim M, Park K, Lee M, Jin T, Seo S . Adiponectin Suppresses UVB-Induced Premature Senescence and hBD2 Overexpression in Human Keratinocytes. PLoS One. 2016; 11(8):e0161247. PMC: 4985158. DOI: 10.1371/journal.pone.0161247. View

17.

Seldeen K, Thiyagarajan R, Redae Y, Jacob A, Troen B, Quigg R . Absence of complement factor H reduces physical performance in C57BL6 mice. Immunobiology. 2020; 225(5):152003. PMC: 9844077. DOI: 10.1016/j.imbio.2020.152003. View

18.

Han R, Frett E, Levy J, Rader E, Lueck J, Bansal D . Genetic ablation of complement C3 attenuates muscle pathology in dysferlin-deficient mice. J Clin Invest. 2010; 120(12):4366-74. PMC: 2993587. DOI: 10.1172/JCI42390. View

19.

Jangravi Z, Tabar M, Mirzaei M, Parsamatin P, Vakilian H, Alikhani M . Two Splice Variants of Y Chromosome-Located Lysine-Specific Demethylase 5D Have Distinct Function in Prostate Cancer Cell Line (DU-145). J Proteome Res. 2015; 14(9):3492-502. DOI: 10.1021/acs.jproteome.5b00333. View

20.

Henriques-Pons A, Yu Q, Rayavarapu S, Cohen T, Ampong B, Cha H . Role of Toll-like receptors in the pathogenesis of dystrophin-deficient skeletal and heart muscle. Hum Mol Genet. 2013; 23(10):2604-17. PMC: 3990161. DOI: 10.1093/hmg/ddt656. View